Patent expiry for drugs means cheaper generics - but only if patients and healthcare systems plan ahead. Learn what changes to expect, how to prepare, and why timing matters more than ever.
Learn More
Specialty medications cost billions but offer powerful treatments. Learn how formulary management, narrow pharmacy networks, biosimilars, and treatment setting changes can slash costs without sacrificing care.
Learn More
Generics make up 90% of U.S. prescriptions but only 12% of drug spending, saving billions annually. Learn how they work, why they’re cheaper, and why they’re the most effective tool for controlling healthcare costs.
Learn More
The FDA's Purple Book is the official guide to approved biosimilars and interchangeable biological products in the U.S. Learn how it works, what interchangeability means, and how it affects your treatment options.
Learn More